IMMUNITRACK ApS: Financial statements 2019
CVR: 32347908
IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -457,365 and a net result of DKK -2,303,315 compared with DKK 1,676,895 the year before. Equity amounted to DKK 6,108,311. The solvency ratio was 68.6%. The company had 6 employees in the financial year.
- Gross Profit
- -457,365 kr.
- Profit/Loss
- -2,303,315 kr.
- Equity
- 6,108,311 kr.
- Total Assets
- 8,901,798 kr.
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -457 t. | -2.3 mio. | 6.1 mio. | 6 |
| 2018 | - | 2.5 mio. | 1.7 mio. | 3.5 mio. | 4 |
| 2017 | - | 1 mio. | 239 t. | 288 t. | - |
| 2016 | - | 483 t. | 23 t. | 49 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout IMMUNITRACK ApS
IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees. In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity amounted to DKK 21,211,816.
